跳至主要内容
临床试验/CTRI/2010/091/001161
CTRI/2010/091/001161已完成4 期

Post marketing surveillance for efficacy and safety evaluation of vitamin-c 15% w/w in facial photodamage

Cipla Ltd0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
Cipla Ltd
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Subjects willing to give written informed consent.
  • 2.Subjects of either sex above 18 years of age.
  • 3.Subjects with diagnosis of early to moderate photodamage
  • 4.In the opinion of the investigator, able to comply with the requirements of the protocol.

排除标准

  • 1.Subjects with hypersensitivity to study drug or any of it?s excipients of its formulation.
  • 2.Judged by Investigator to be inappropriate as subjects.

研究者

发起方
Cipla Ltd

相似试验